Condensed Statements of Preferred Stock and Stockholders' Equity/(Deficit) (Unaudited) - USD ($) $ in Thousands	Total	Series Seed Convertible Preferred Stock [Member]	Series A Convertible Preferred Stock [Member]	Series B Convertible Preferred Stock [Member]	Common Stock [Member]	Preferred Stock [Member]	Additional Paid-In Capital [Member]	Accumulated Other Comprehensive Gain (Loss)	Accumulated Deficit [Member]
Temporary equity, Balance at Dec. 31, 2020		$ 4,486	$ 19,908	$ 44,790
Temporary equity, Balance (in shares) at Dec. 31, 2020		6,520,790	12,932,429	19,373,169
Balance at Dec. 31, 2020	$ (51,555)				$ 1		$ 1,552	$ 17	$ (53,125)
Balance (in shares) at Dec. 31, 2020					10,816,937
Vesting of common stock issued for early exercise of stock options	92						92
Vesting of common stock issued for early exercise of stock options (in shares)					151,343
Issuance of common stock in connection with exercise of stock options	995						995
Issuance of common stock in connection with exercise of stock options (in shares)					1,855,904
Stock-based compensation	1,096						1,096
Unrealized gain (loss) on available- for-sale marketable securities	(49)							(49)
Net loss	(23,921)								(23,921)
Temporary equity, Balance at Mar. 31, 2021		$ 4,486	$ 19,908	$ 44,790
Temporary equity, Balance (in shares) at Mar. 31, 2021		6,520,790	12,932,429	19,373,169
Balance at Mar. 31, 2021	(73,342)				$ 1		3,735	(32)	(77,046)
Balance (in shares) at Mar. 31, 2021					12,824,184
Temporary equity, Balance at Dec. 31, 2020		$ 4,486	$ 19,908	$ 44,790
Temporary equity, Balance (in shares) at Dec. 31, 2020		6,520,790	12,932,429	19,373,169
Balance at Dec. 31, 2020	(51,555)				$ 1		1,552	17	(53,125)
Balance (in shares) at Dec. 31, 2020					10,816,937
Conversion of Preferred Stock To Common Stock	69,184
Net loss	(61,400)
Balance at Jun. 30, 2021	366,578				$ 7		481,079	17	(114,525)
Balance (in shares) at Jun. 30, 2021					71,526,327
Temporary equity, Balance at Mar. 31, 2021		$ 4,486	$ 19,908	$ 44,790
Temporary equity, Balance (in shares) at Mar. 31, 2021		6,520,790	12,932,429	19,373,169
Balance at Mar. 31, 2021	(73,342)				$ 1		3,735	(32)	(77,046)
Balance (in shares) at Mar. 31, 2021					12,824,184
Conversion of Preferred Stock To Common Stock	69,184	$ (4,486)	$ (19,908)	$ (44,790)	$ 4		69,180
Conversion of preferred stock into common stock, converted (in shares)		(6,520,790)	12,932,429	19,373,169	38,826,388
Conversion of the convertible promissory notes into common stock	165,699				$ 1		165,698
Conversion of the convertible promissory notes into common stock (in shares)					7,531,777
Issuance of common stock upon initial public offering, net of issuance costs	237,199				$ 1		237,198
Issuance of common stock upon initial public offering, net of issuance costs (in shares)					11,730,000
Cashless exercise of common stock warrant	2,631						2,631
Cashless exercise of common stock warrant (in shares)					117,088
Vesting of common stock issued for early exercise of stock options	230						230
Vesting of common stock issued for early exercise of stock options (in shares)					378,146
Issuance of common stock in connection with exercise of stock options	66						66
Issuance of common stock in connection with exercise of stock options (in shares)					118,744
Stock-based compensation	2,341						2,341
Unrealized gain (loss) on available- for-sale marketable securities	49							49
Net loss	(37,479)								(37,479)
Balance at Jun. 30, 2021	366,578				$ 7		481,079	17	(114,525)
Balance (in shares) at Jun. 30, 2021					71,526,327
Temporary equity, Balance (in shares) at Dec. 31, 2021			0
Balance at Dec. 31, 2021	336,173				$ 7		488,200	(138)	(151,896)
Balance (in shares) at Dec. 31, 2021					72,438,742
Exchange of common stock for Series A Common Stock Equivalent (in shares)					(2,500,000)	2,500
Vesting of common stock issued for early exercise of stock options	344						344
Vesting of common stock issued for early exercise of stock options (in shares)					505,322
Issuance of common stock in connection with exercise of stock options	34						34
Issuance of common stock in connection with exercise of stock options (in shares)					65,399
Stock-based compensation	3,566						3,566
Unrealized gain (loss) on available- for-sale marketable securities	(629)							(629)
Net loss	(22,006)								(22,006)
Balance at Mar. 31, 2022	317,482				$ 7		492,144	(767)	(173,902)
Balance (in shares) at Mar. 31, 2022					70,509,463	2,500
Temporary equity, Balance (in shares) at Dec. 31, 2021			0
Balance at Dec. 31, 2021	$ 336,173				$ 7		488,200	(138)	(151,896)
Balance (in shares) at Dec. 31, 2021					72,438,742
Exchange of common stock for Series A Common Stock Equivalent (in shares)	38,826,388	6,520,790
Conversion of Preferred Stock To Common Stock	$ 0
Issuance of common stock in connection with exercise of stock options (in shares)	228,043
Net loss	$ (45,988)
Temporary equity, Balance (in shares) at Jun. 30, 2022			2,500
Balance at Jun. 30, 2022	297,561				$ 7		496,451	(1,013)	(197,884)
Balance (in shares) at Jun. 30, 2022					71,065,869	2,500
Balance at Mar. 31, 2022	317,482				$ 7		492,144	(767)	(173,902)
Balance (in shares) at Mar. 31, 2022					70,509,463	2,500
Vesting of common stock issued for early exercise of stock options	151						151
Vesting of common stock issued for early exercise of stock options (in shares)					219,743
Issuance of common stock in connection with exercise of stock options	62						62
Issuance of common stock in connection with exercise of stock options (in shares)					162,644
Issuance of common stock in connection with Employee Stock Purchase Program	489						489
Issuance of common stock in connection with Employee Stock Purchase Program (in shares)					174,019
Stock-based compensation	3,605						3,605
Unrealized gain (loss) on available- for-sale marketable securities	(246)							(246)
Net loss	(23,982)								(23,982)
Temporary equity, Balance (in shares) at Jun. 30, 2022			2,500
Balance at Jun. 30, 2022	$ 297,561				$ 7		$ 496,451	$ (1,013)	$ (197,884)
Balance (in shares) at Jun. 30, 2022					71,065,869	2,500